Interaction of Moloney murine leukemia virus matrix protein with IQGAP

Juliana Leung1, Andrew Yueh, Frank S K Appah

  • 1Integrated Program in Cellular, Molecular, and Biophysical Studies, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

The EMBO Journal
|April 22, 2006
PubMed

Insights

Moloney murine leukemia virus matrix protein (MA) binds IQGAP1, a cytoskeleton regulator. This interaction is crucial for virus replication, with defects in binding halting the viral life cycle.

Area of Science:

  • Virology
  • Cell Biology
  • Molecular Biology

Background:

  • The Moloney murine leukemia virus (M-MuLV) matrix protein (MA) plays a role in viral assembly and entry.
  • IQGAP1 is a key regulator of the actin cytoskeleton, influencing cell shape, motility, and intracellular trafficking.

Purpose of the Study:

  • To investigate the interaction between M-MuLV MA and IQGAP1.
  • To determine the functional significance of this interaction for M-MuLV replication.

Main Methods:

  • Site-directed mutagenesis of M-MuLV MA to identify critical interaction residues.
  • Virus replication assays to assess the impact of MA mutations.
  • In vitro and in vivo binding assays to confirm MA-IQGAP1 interaction.
  • RNA interference (RNAi) to knockdown IQGAP1 expression.

Main Results:

  • Specific residues in M-MuLV MA were identified as critical for IQGAP1 binding.
  • Mutations disrupting MA-IQGAP1 interaction led to replication-defective viruses with defects in multiple life cycle stages.
  • Second-site revertant viruses restored IQGAP1 binding and replication competence.
  • IQGAP1 knockdown or inhibition with a C-terminal fragment impaired virus replication.

Conclusions:

  • The interaction between M-MuLV MA and IQGAP1 is essential for efficient virus replication.
  • IQGAP1 likely facilitates viral trafficking by linking the virus to the host cell cytoskeleton.
  • Targeting the MA-IQGAP1 interaction could be a strategy for antiviral therapy.